Xenobiotic efflux pumps in isolated fish brain capillaries
- 1 January 2002
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 282 (1) , R191-R198
- https://doi.org/10.1152/ajpregu.00305.2001
Abstract
To identify specific transporters that drive xenobiotics from the central nervous system to blood, the accumulation of fluorescent drugs was studied in isolated capillaries from killifish and dogfish shark brain using confocal microscopy and quantitative image analysis. In killifish brain capillaries, luminal accumulation of fluorescent derivatives of cyclosporin A and verapamil was concentrative, specific, and energy dependent (inhibition by KCN). Transport was reduced by PSC-833, but not by leukotriene C4, indicating the involvement of P-glycoprotein. The ability of capillaries to transport the cyclosporin A derivative was unchanged over 20 h, demonstrating the long-term viability of the preparation. Luminal accumulation of the fluorescent organic anions sulforhodamine 101 and fluorescein-methotrexate was also concentrative, specific, and energy dependent. Transport of these compounds was reduced by leukotriene C4, but not by PSC-833, indicating the involvement of a multidrug resistance-associated protein (Mrp). Similar results were obtained for isolated capillaries from dogfish shark. Immunostaining localized P-glycoprotein and Mrp2 to the luminal surface of the killifish brain capillary endothelium. These findings validate a new and long-lived comparative model for studying drug transport across the blood-brain barrier and, as in mammals, implicate P-glycoprotein and Mrp2 in transport from the central nervous system to blood in fish.Keywords
This publication has 20 references indexed in Scilit:
- Ivermectin excretion by isolated functionally intact brain endothelial capillariesBritish Journal of Pharmacology, 2001
- The Role of P-Glycoprotein and Canalicular Multispecific Organic Anion Transporter in the Hepatobiliary Excretion of DrugsJournal of Pharmaceutical Sciences, 1998
- Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.Journal of Clinical Investigation, 1997
- Functional Expression of P‐Glycoprotein in an Immortalised Cell Line of Rat Brain Endothelial Cells, RBE4Journal of Neurochemistry, 1996
- Evidence for P‐glycoprotein‐modulated penetration of morphine‐6‐glucuronide into brain capillary endotheliumBritish Journal of Pharmacology, 1996
- P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.Journal of Clinical Investigation, 1996
- Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoproteinBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- High levels of P-glycoprotein detected in isolated brain capillariesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1993
- Energy state of bovine cerebral microvessels: Comparison of isolation methodsMicrovascular Research, 1988